Acompanhe as Notícias da Recifes

Vanderbilt researchers created the first selective compound designed to inhibit TAOK-1, a poorly understood protein connected to Alzheimer’s disease. They also discovered a second compound that activates the entire TAOK protein family, offering scientists an unexpected new resear

Genetic changes may set off a chain reaction that causes the spine’s natural shock absorbers to harden and deteriorate. Zebrafish with a faulty collagen-related gene developed mineral buildup and spinal fusion similar to human disc disease. Researchers were able to reduce the dam

Neck and low back pain affect millions worldwide and are a leading cause of disability. Degeneration of the disks that cushion the spine is a leading cause. Current treatments can relieve symptoms but do little to slow the underlying disease. Now, researchers from Thomas Jefferso

Modern medicine has become increasingly focused on preventing disease and extending healthy life, but a new paper claims that the next major leap in health care will require something more fundamental: ensuring that both medical care and scientific knowledge are accessible to eve

A one-size-fits-all approach likely isn't the best strategy when designing artificial intelligence systems that assist users in disease diagnosis.

The meningococcal B (MenB) vaccine could provide protection against more than one disease, with new research linking it to a significant reduction in the risk of gonorrhea in young Territorians. The study, led by Adelaide University in partnership with NT Health, found that two d

A new study co-led by professor Valeriya Malysheva, group leader at the VIB-UAntwerp Center for Molecular Neurology, published in Nature Genetics, uncovers how the three-dimensional organization of DNA in rare immune cells can help explain genetic risk for Crohn's disease and oth

A drug-free technology that uses low-intensity electric fields reduces tumor growth and spread in preclinical models of triple-negative breast cancer, one of the most aggressive forms of the disease, according to new research from The Ohio State University Comprehensive Cancer Ce

An international study led by Mayo Clinic researchers has identified interleukin-6 (IL-6) receptor blockers as a promising option for preventing relapses in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). MOGAD is a rare autoimmune neurological disorder t

Acute myeloid leukemia (AML) is an aggressive blood cancer that remains difficult to treat. While targeted therapies have improved outcomes for some patients, many relapse when a small population of cancer stem cells survives treatment and seeds the disease again.

Malaria is an ancient disease, dating back to 4,000–3,000 B.C., according to genetic evidence. Two hundred fifty million people are infected each year, and 610,000 cases are fatal. UIC researchers have developed a new antimalarial drug designed to thwart even the most drug-resist

Whether you are first-born or second-born may be associated with your risk of developing certain diseases, according to a new study published in Nature Health.